A new lipid-structured model to investigate the opposing effects of LDL and HDL on atherosclerotic plaque macrophages
Keith L Chambers, Mary R Myerscough, Helen M Byrne

TL;DR
This study introduces a lipid-structured mathematical model to analyze how LDL and HDL levels influence lipid accumulation in plaque macrophages, revealing dynamics that could explain impaired efferocytosis in atherosclerosis.
Contribution
The paper presents a novel lipid-structured model that captures the effects of LDL and HDL on macrophage lipid distribution and plaque composition, with analytical and numerical insights.
Findings
Plaque lipid content is sensitive to LDL/HDL balance.
Macrophage lipid distribution can be monotone, quasi-uniform, or unimodal.
Lipid accumulation may impair macrophage efferocytosis.
Abstract
Atherosclerotic plaques form in artery walls due to a chronic inflammatory response driven by lipid accumulation. A key component of the inflammatory response is the interaction between monocyte-derived macrophages and extracellular lipid. Although concentrations of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particles in the blood are known to affect plaque progression, their impact on the lipid load of plaque macrophages remains unexplored. In this paper, we develop a lipid-structured mathematical model to investigate the impact of blood LDL/HDL levels on plaque composition, and lipid distribution in plaque macrophages. A reduced subsystem, derived by summing the equations of the full model, describes the dynamics of biophysical quantities relating to plaque composition (e.g. total number of macrophages, total amount of intracellular lipid). We also derive a…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPhagocytosis and Immune Regulation · Adipokines, Inflammation, and Metabolic Diseases · Atherosclerosis and Cardiovascular Diseases
